Michael Anger, MD, FACP, FASN
Senior Vice President and Chief Medical Officer, Renal Therapies Group, Fresenius Medical Care North America; and Chief Medical Officer, Frenova Renal Research
Michael Anger is senior vice president and chief medical officer of the Renal Therapies Group of FMCNA and chief medical officer of Frenova. He is clinical professor of medicine at the University of Colorado School of Medicine, a fellow of the American College of Physicians, a fellow of the American Society of Nephrology, and a member of the honor medical society Alpha Omega Alpha. Prior to joining Fresenius, Dr. Anger was the chief medical officer of American Renal Associates, as well as president and senior partner of Western Nephrology in Denver, Colorado, where he led the research division and interventional nephrology. He received his medical training at Hahnemann University, where he also did his internal medicine residency, and he completed his adult and pediatric nephrology fellowships at the University of Colorado School of Medicine.
Substantial Clinical Improvement: Optimizing CMS Guidelines For New Products
Genomics and Precision Medicine: The Frenova Genomics Registry